Literature DB >> 7969964

Primary auditory pathway and reticular activating system dysfunction in Alzheimer's disease.

D O'Mahony1, M Rowan, J Feely, J B Walsh, D Coakley.   

Abstract

Patients with Alzheimer's disease (AD) have pathologic involvement of several important components of the primary auditory pathway, including the inferior colliculus, medial geniculate body, primary auditory cortex, and secondary auditory cortex. The main components of the brainstem auditory evoked response (BAER) and middle latency response (MLR) reflect the function of portions of the primary auditory pathway, including those affected pathologically in AD. The amplitude of the P1 component of the MLR reflects the degree of neuronal activity of midbrain portions of the ascending reticular activating system (ARAS) with cortical cholinergic projections. To determine whether there is dysfunction of the primary auditory pathway and ARAS in AD, we compared simultaneous BAER and MLR component latency and amplitude measurements in patients with mild-moderate AD (n = 35) and age-matched healthy elderly controls (n = 34). There were significant latency delays in brainstem transmission time (BAER I-V interpeak latency; p < 0.05) and in primary auditory cortex evoked potential generation (MLR Pa latency; p < 0.05) in the AD group compared with controls. In addition, there was a significant reduction in the P1 component amplitude of the MLR in the AD group (p < 0.01). These results indicate dysfunction of the primary auditory pathway and ARAS in patients with mild-moderate AD and support the hypothesis that impairment of auditory function and of arousal are intrinsic features of AD.

Entities:  

Mesh:

Year:  1994        PMID: 7969964     DOI: 10.1212/wnl.44.11.2089

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  8 in total

1.  The auditory P50 component to onset and offset of sound.

Authors:  Hillel Pratt; Arnold Starr; Henry J Michalewski; Naomi Bleich; Nomi Mittelman
Journal:  Clin Neurophysiol       Date:  2007-12-04       Impact factor: 3.708

2.  Hearing loss is an early biomarker in APP/PS1 Alzheimer's disease mice.

Authors:  Yang Liu; Shu Fang; Li-Man Liu; Yan Zhu; Chang-Ri Li; Kaitian Chen; Hong-Bo Zhao
Journal:  Neurosci Lett       Date:  2019-12-20       Impact factor: 3.046

3.  Astrocytic gap junctional communication is reduced in amyloid-β-treated cultured astrocytes, but not in Alzheimer's disease transgenic mice.

Authors:  Nancy F Cruz; Kelly K Ball; Gerald A Dienel
Journal:  ASN Neuro       Date:  2010-08-17       Impact factor: 4.146

4.  Trafficking of glucose, lactate, and amyloid-beta from the inferior colliculus through perivascular routes.

Authors:  Kelly K Ball; Nancy F Cruz; Robert E Mrak; Gerald A Dienel
Journal:  J Cereb Blood Flow Metab       Date:  2009-09-30       Impact factor: 6.200

Review 5.  Trigeminal, Visceral and Vestibular Inputs May Improve Cognitive Functions by Acting through the Locus Coeruleus and the Ascending Reticular Activating System: A New Hypothesis.

Authors:  Vincenzo De Cicco; Maria P Tramonti Fantozzi; Enrico Cataldo; Massimo Barresi; Luca Bruschini; Ugo Faraguna; Diego Manzoni
Journal:  Front Neuroanat       Date:  2018-01-08       Impact factor: 3.856

6.  Cholinergic Hypofunction in Presbycusis-Related Tinnitus With Cognitive Function Impairment: Emerging Hypotheses.

Authors:  Qingwei Ruan; Zhuowei Yu; Weibin Zhang; Jian Ruan; Chunhui Liu; Ruxin Zhang
Journal:  Front Aging Neurosci       Date:  2018-04-06       Impact factor: 5.750

7.  Contribution of psychoacoustics and neuroaudiology in revealing correlation of mental disorders with central auditory processing disorders.

Authors:  V Iliadou; S Iakovides
Journal:  Ann Gen Hosp Psychiatry       Date:  2003-05-20

8.  Investigating Auditory Electrophysiological Measures of Participants with Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review and Meta-Analysis of Event-Related Potential Studies.

Authors:  Hadeel Y Tarawneh; Wilhelmina H A M Mulders; Hamid R Sohrabi; Ralph N Martins; Dona M P Jayakody
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.